Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C10H13FN2O5 |
Molecular Weight | 260.219 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N2C=CC(=O)NC2=O
InChI
InChIKey=ARKKGZQTGXJVKW-VPCXQMTMSA-N
InChI=1S/C10H13FN2O5/c1-10(11)7(16)5(4-14)18-8(10)13-3-2-6(15)12-9(13)17/h2-3,5,7-8,14,16H,4H2,1H3,(H,12,15,17)/t5-,7-,8-,10-/m1/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/16107149Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/17999967 | https://www.ncbi.nlm.nih.gov/pubmed/26037157
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16107149
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/17999967 | https://www.ncbi.nlm.nih.gov/pubmed/26037157
RO-2433 (GS-331007, formerly PSI-6206) is inactive metabolite of Sofosbuvir, a modern antiviral drugs for the treatment of chronic hepatitis C.
Originator
Approval Year
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16107149
HCV replicon RNA-containing Huh7 cells (clone A cells; Apath, LLC, St. Louis, Mo.) were kept at exponential growth in Dulbecco’s modified Eagle’s medium (high glucose, no pyruvate) containing 10% fetal bovine serum, 1x nonessential amino acids, penicillin-streptomycin-glutamine (100 U/ml, 100 mkg/ml, and 0.292 mg/ml, respectively), and G418 (500 to 1,000 mkg/ml). Antiviral assays were performed in the same medium without G418. Cells were seeded in a 96-well plate at 1,000 cells per well, and test compound 9 (RO-2433) were added immediately after seeding. Incubation times differed according to the type of experiment. At the end of the incubation step, total cellular RNA was isolated (RNeasy 96 kit; Qiagen). Replicon RNA and an internal control (Taq- Man rRNA control reagents; Applied Biosystems) were amplified in a single-step multiplex RT-PCR protocol as recommended by the manufacturer.
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID30462011
Created by
admin on Sat Dec 16 08:04:00 GMT 2023 , Edited by admin on Sat Dec 16 08:04:00 GMT 2023
|
PRIMARY | |||
|
863329-66-2
Created by
admin on Sat Dec 16 08:04:00 GMT 2023 , Edited by admin on Sat Dec 16 08:04:00 GMT 2023
|
PRIMARY | |||
|
11311503
Created by
admin on Sat Dec 16 08:04:00 GMT 2023 , Edited by admin on Sat Dec 16 08:04:00 GMT 2023
|
PRIMARY | |||
|
44V7045CXS
Created by
admin on Sat Dec 16 08:04:00 GMT 2023 , Edited by admin on Sat Dec 16 08:04:00 GMT 2023
|
PRIMARY |
PARENT (METABOLITE INACTIVE)
SUBSTANCE RECORD